Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Keloid tissue: active keloid lesion vs. adjacent normal skin tissue

ABSTRACT: Transcriptional profiling of active keloid lesion and adjacent control normal skin tissue from human. Each control and lesion sample was derived from a matched individual.

ORGANISM(S): Homo sapiens

PROVIDER: GSE90051 | GEO | 2017/07/01

SECONDARY ACCESSION(S): PRJNA354398

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Keratinocyte and fibroblast gene expression in skin and keloid scar tissue

Project description:Keloids are scars that extend beyond original wounds and are resistant to treatment. In order to improve understanding of the molecular basis of keloid scarring, we have assessed the genomic profiles of keloid fibroblasts and keratinocytes. Skin and scar tissues were obtained for isolation of primary keratinocytes and fibroblasts. Keloid scars were excised from patients undergoing scar excision surgery, normal skin samples were isolated from patients undergoing elective plastic surgery. Primary culters were prepared for keratinocytes and fibroblasts, and were harvested for analysis up to passage three. Nine keloid scars, for adjacent non-lesional keloid skin samples, and three normal skin samples were obtained and cultured. RNA was isolated using RNeasy, and quality verified using an Agilent 2100 Bioanalyzer. Labeling and hybridization to Affymetrix Human Gene 1.0 ST microarray chips was performed by the Vanderbilt Genome Sciences Resource at Vanderbilt University Medical Center.

2013-05-28 | E-GEOD-44270 | biostudies-arrayexpress

small non-codingRNA in Human keloid scar tissue and normal skin tissue

Project description:We selected 3 pairs of keloid and normal skin matched by age and site of onset to observe the expression difference of small noncoding RNA

2022-01-19 | E-MTAB-11336 | biostudies-arrayexpress

Quantitative proteomic analysis of keloid scars and normal skin tissues

Project description:Keloid scars is a pathologic fibro-proliferative disorders of the skin, which exhibit abnormal phenotypes including fibroblasts proliferation and collagen deposits. There have been several treatments of keloids including conventional surgical therapies and adjuvant therapies, but a high recurrence rate of keloids was also observed after treatment. Quantitative proteomics approach has been proved an efficient approach to investigate pathological mechanism and novel biomarkers. In this study, we present a label-free quantitative proteomics analysis to explore differential protein expression profiles in normal skin and keloid scar tissues based on nano-liquid chromatography and tandem mass spectrometry (Nano-LC–MS/MS). The study results displayed a more comprehensive keloid protein expression landscape and provided novel pathological insight of keloid.

2023-03-11 | PXD029631 | Pride

Keratinocyte and fibroblast gene expression in skin and keloid scar tissue

2013-05-28 | GSE44270 | GEO

RNA sequencing of keratinocyte gene expression in keloid and normal skin tissue

Project description:RNA sequencing has been performed to investigate the transcriptomic profile of keratinocyte derived from keloid and normal skin tissue. Keratinocytes of low passage (p2-4) were cultured onto T25 flasks until full confluence was reached. Keratinocytes were then harvested by trypsinization using 0.05% trypsin-EDTA and washed in Phosphate Buffered Saline (PBS). RNA was extracted using the RNeasy Mini kit protocol. Samples were then sent to the Australian Genome Research Facility (AGRF) where 1μg of RNA was submitted for next-generation sequencing. Once raw data returned, bioinformatics analyses were conducted. Through RNA-seq and bioinformatics analysis, 252 differentially expressed genes were identified in keloid keratinocytes compared to normal skin keratinocytes. Further gene ontology (GO) and Kyoto Encyclopaedia of Genes and Genomes (KEGG) analyses revealed that changes in tight junctions and dysregulated response to viral infection were associated with keloid epithelia and may be linked to the disease. The results of the transcriptome analysis intimate that keloid derived keratinocytes exhibit an abnormal gene expression profile and the abnormalities in keloid keratinocytes may have an important role in keloid pathogenesis.

2021-10-06 | GSE185309 | GEO

Gene expression profile of keloid tissue

Project description:Comparison of keloid to normal tissue Keywords: examination of keloid tissue

2005-07-16 | GSE2945 | GEO

Project description:To identify differentially expressed EMT-related lncRNAs between keloid and adjacent normal skin specimens

2021-08-18 | GSE182192 | GEO

Gene expression profile of keloid tissue

Project description:Comparison of keloid to normal tissue One sample for each type of tissue examined

2010-07-01 | E-GEOD-2945 | biostudies-arrayexpress

Homo sapiens

Project description:Keloid tissue: active keloid lesion vs. adjacent normal skin tissue

| PRJNA354398 | ENA

Next Generation Sequencing Facilitates Quantitative Analysis of keloid and normal skin

Project description:Purpose: This study aimed to investigate the role of dysregulated circRNAs in keloid. Methods: High-throughput sequencing was used to detect the changes of circRNAs, microRNAs(miRNAs) and mRNAs in 3 samples of keloid and corresponding normal skin.Based on Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) Pathway enrichment analysis combining several signaling pathways associated with keloid formation and progression, we screened these differentially expressed circRNAs.qRT–PCR validation was performed using TaqMan and SYBR Green assays Results: Compared with normal controls, there were an average of 120 and 12 circRNAs, 44 and 63 miRNAs, 656 and 156 mRNAs were up-regulated and down-regulated, respectively, in keloids. Conclusions: This study implicates that the abnormal expression of circRNAs in cases of keloid may correlate with its pathological process.

2023-05-27 | GSE151464 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data